A New Hope for Precision Medicine

See allHide authors and affiliations

Science Translational Medicine  23 Oct 2013:
Vol. 5, Issue 208, pp. 208fs38
DOI: 10.1126/scitranslmed.3007622

You are currently viewing the abstract.

View Full Text


The SS1P immunotoxin is combined with immunomodulatory therapy in order to improve its efficacy in human mesothelioma (Hassan et al., this issue).

View Full Text